Progyny (PGNY) Operating Expenses (2018 - 2026)

Progyny (PGNY) has 9 years of Operating Expenses data on file, last reported at $47.7 million in Q1 2026.

• On a quarterly basis, Operating Expenses fell 7.62% year-over-year to $47.7 million in Q1 2026; TTM through Mar 2026 was $215.3 million, a 11.17% increase from a year earlier, with the FY2025 full-year figure at $219.2 million, up 17.91% from the prior year.
• Operating Expenses for Q1 2026 stood at $47.7 million, down from $61.7 million in the prior quarter.
• Over the last five years, Operating Expenses for PGNY reached as high as $61.7 million in Q4 2025 and fell as low as $33.0 million in Q1 2022.
• Historically, Operating Expenses has averaged $45.5 million across 5 years, with a median of $45.5 million in 2023.
• Across the five-year window, Operating Expenses jumped 95.1% in 2022 and slipped 7.62% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $41.2 million in 2022, then grew by 4.63% to $43.1 million in 2023, then gained by 10.56% to $47.6 million in 2024, then grew by 29.41% to $61.7 million in 2025, then declined by 22.65% to $47.7 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $47.7 million in Q1 2026, $61.7 million in Q4 2025, and $51.3 million in Q3 2025.